Latest / The Audio Edition / Federal Regulators Blindfold Doctors to Enrich Health Tech Monopolies
Transcript
- Federal Regulators Blindfold Doctors to Enrich Health Tech Monopolies. By Vince Kaczmarek. October 31, 2026. This article is read by an AI-generated voice. If you want to understand how Washington converts human vulnerability into private balance-sheet liquidity, look past the campaign rallies and open the October 28, 2026, issue of the Federal Register. There, tucked inside eighty-three dense pages of bureaucratic sleep aid titled “Health Data, Technology, and Interoperability: ONC Deregulatory Actions to Unleash Prosperity”—known in the trade as HTI-5—the federal government executed one of the cleanest corporate heists of the decade. With the stroke of an administrative pen, the Department of Health and Human Services (HHS) and its Office of the National Coordinator for Health Information Technology (ONC) stripped away every federal requirement forcing electronic health record monopolies to show doctors how their clinical artificial intelligence models actually work. The price tag on this regulatory arson was not hidden in a locked safe. Regulators published it in black and white: the rule hands health technology developers an estimated $1.55 billion net-present-value windfall in compliance savings. In exchange for saving a handful of entrenched tech conglomerates $108.1 million a year, federal regulators agreed to blindfold physicians, strip clinical algorithms of safety guardrails, and turn American patients into unwitting guinea pigs for proprietary software that cannot be inspected, audited, or challenged. The Paperwork Excuse. The public relations cover for this surrender was the usual bipartisan cant about unleashing American innovation and slashing red tape. President Donald Trump set the stage with Executive Order 14192, an order mandating the systematic purging of regulatory baselines across federal agencies. HHS Secretary Robert F. Kennedy Jr. promptly delivered the corporate spoils. In an official agency statement on October 26, 2026, Kennedy announced the giveaway without a trace of irony: American doctors and patients need better technology, not more Washington paperwork. The Trump Administration is eliminating unnecessary regulations that cost more than $1.5 billion and hold back innovation. We are freeing America’s health technology innovators to build better tools, lower costs, and help doctors spend more time caring for patients. National Coordinator for Health IT Tom Keane struck the same pious note during his press briefing, insisting that gutting the rules would liberate noble software vendors from needless burdens: The practical effect is to free up resources for developers. Instead of spending that time and money complying with requirements that are no longer necessary, developers can focus on innovative solutions that advance interoperability, automation, and ultimately better experiences for patients and clinicians. To understand the sheer cynicism of this pitch, you have to understand what federal regulators just classified as unnecessary paperwork. In January 2024, ONC finalized a benchmark rule known as HTI-1 under the statutory mandate of the bipartisan 21st Century Cures Act. For years, hospitals had been deploying algorithmic clinical decision-support interventions—automated software systems that prompt doctors on everything from emergency room sepsis triage to cancer risk, readmission scores, and drug dosages. Most of these algorithms were sold as proprietary black boxes. Doctors had no idea what clinical data had trained them, whether they had ever been tested on populations like their own patients, or how often they misfired. HTI-1 imposed a straightforward baseline. Under Section 170.315(b)(11) of Title 45 of the Code of Federal Regulations, any health IT vendor seeking federal certification had to supply standardized source attributes—essentially clinical nutrition labels or model cards—for predictive tools. Developers had to disclose thirty-one plain-language technical facts: the demographic makeup of the training data, testing methods, known algorithmic bias, validation metrics, clinical purpose, and operational limitations. Furthermore, vendors had to maintain Intervention Risk Management practices, meaning they were legally obligated to monitor their own models for drift, diagnostic inaccuracies, and racial or socioeconomic discrimination. Vendors were not barred from selling software. They were simply told that if they wanted public certification to sell diagnostic systems into Medicare-funded hospitals, they had to prove their machines were fair, appropriate, valid, effective, and safe. That regulatory framework, known as the FAVES standard, took years of public testimony, clinical warnings, and epidemiological data to construct. It took the Trump administration’s health officials just a few months to tear it down. The Gutter-Level Reality of the Black Box. Under HTI-5, every single one of those thirty-one mandatory source attributes has been erased. The requirement for ongoing algorithmic risk management has been eliminated. In total, the final rule cuts fourteen certification criteria from the federal program’s sixty-standard baseline and modifies seven others, quietly junking performance rules for clinical summaries, automated quality measures, and patient data capture. The agency’s formal justification in the Federal Register reads like a dark satire of regulatory capture. Regulators wrote that they found no publicly available evidence indicating that a single doctor, nurse, or administrator has accessed, recorded, or modified a single source attribute since the predictive intervention rules were drafted. Because exhausted physicians working twelve-hour hospital shifts had not yet spent their few free seconds combing through technical model cards, the agency concluded that the disclosures served no purpose. Their official advice to frontline doctors? The agency noted that we encourage users of certified health IT to ask their developers for such information rather than forcing vendors to provide it by law. Imagine the Federal Aviation Administration announcing that because commercial airline pilots rarely read Boeing’s raw avionics flight-control code during a midair stall, the agency will no longer require aircraft manufacturers to certify that automated steering software works. If pilots want to know whether a sensor will throw the plane into an unrecoverable dive, they can simply ask the contractor for a voluntary summary over the phone. That is the administrative logic HHS just codified for hospital operating rooms and intensive care units. The idea that a local community clinic or a county public hospital can simply ask a multibillion-dollar electronic health records vendor for proprietary algorithmic weights—and receive a truthful, comprehensible answer—is an insult to anyone who has ever signed an enterprise software license. The health software industry in the United States is not a competitive market of plucky startup innovators. It is a consolidated oligopoly. A tiny cabal of monopolists, led by Epic Systems, Oracle Health, and MEDITECH, controls the digital infrastructure of American medicine. More than 96 percent of non-federal acute care hospitals and 78 percent of office-based physicians run on certified health IT. These hospital systems are locked into ironclad, multimillion-dollar vendor contracts. If a rural hospital administrator calls Epic or Oracle to demand the validation datasets for a predictive sepsis alert, the software rep can laugh, invoke trade-secret protections, and hang up. Under HTI-5, federal law gives the developer complete legal cover to do exactly that. The Derivative Swaps of Modern Medicine. Washington has run this deregulatory grift before. In the late 1990s and 2000, Wall Street investment banks besieged Capitol Hill with warnings that federal oversight was stifling financial genius. They demanded the deregulation of over-the-counter financial derivatives, arguing that complex credit default swaps and collateralized debt obligations were private contracts between sophisticated counterparties who did not require the heavy hand of government disclosure. Alan Greenspan and congressional leaders from both parties agreed, passing the Commodity Futures Modernization Act of 2000. The result was the creation of a massive, unmonitored shadow banking system. When quantitative risk models proved to be catastrophic fictions built on subprime rot, the financial system imploded, leaving ordinary homeowners and workers to pay for the fallout while the architects of the scam collected bonuses. In HTI-5, HHS has imported the exact same playbook into health care. Once again, regulators insist that private market counterparties can regulate themselves without statutory disclosure mandates. Once again, public transparency is treated as an intolerable drag on corporate revenue. Yet the parallel exposes something even darker. When Wall Street ran its derivative casino, the damage was financial: toxic balance sheets, foreclosures, and taxpayer-funded bailouts. When health IT monopolists deploy untested predictive models, the damage is biological. Algorithmic bias in medicine is not a hypothetical anxiety dreamed up by bureaucrats; it is a documented reality. Landmark peer-reviewed studies have demonstrated that commercial risk-prediction software systematically discriminated against Black patients because the algorithms used historical health care spending as a proxy for illness severity. Because poor and nonwhite patients faced systemic barriers that suppressed their medical expenditures, the algorithms calculated that they were healthier than white patients with the exact same chronic illnesses, cutting them off from specialized care programs. The FAVES rules and mandatory model cards were designed specifically to prevent software vendors from hardcoding those disparities into hospital software. By erasing those rules, HHS ensures that when an algorithm steers treatment away from vulnerable populations, the bias remains invisible, buried deep inside proprietary corporate code. The financial analogy breaks down in another critical respect: the extreme asymmetry of power. Wall Street investment banks were trading with hedge funds and corporate treasuries that employed their own small armies of quantitative analysts. A regional hospital, an urban safety-net clinic, or an overburdened primary care physician has no quantitative team capable of auditing deep-learning algorithms. By eliminating public certification tests, the federal government leaves physicians entirely at the mercy of corporate sales decks. The Voluntary Benevolence Sham. Two days after HHS published its deregulatory gift, the industry demonstrated exactly how this power dynamic will play out. On October 30, 2026, Epic Systems—which controls over 39 percent of the hospital electronic medical records market—took to social media to reassure the public. In a corporate announcement, the company proclaimed: Epic is committed to meaningful AI transparency and health systems using Epic will retain access to all the tools we’ve created to help evaluate the fairness, validity, and other attributes of our software. Notice the language. Epic will not be complying with a binding federal statute enforceable by civil penalties and public audits. Instead, hospitals will be granted access to proprietary evaluation tools out of the vendor’s voluntary goodwill. Transparency is no longer a public right; it is a private corporate feature, subject to vendor terms of service, intellectual property paywalls, and nondisclosure agreements. This is the classic corporate unbundling shell game. Health care provider organizations warned ONC during the public comment period that stripping capabilities out of the federal certification baseline never reduces costs for health systems. Instead, it allows monopolistic vendors to unbundle previously mandatory features and sell them back to cash-strapped hospitals as expensive, premium add-ons. If a hospital wants audit logs, algorithmic fairness dashboards, or model validation data, it can write a new check to the vendor for an enterprise AI governance module. Even worse is where the legal liability lands. In its regulatory analysis, corporate law firm Reed Smith noted that ONC finalized the repeal of AI model cards even though a large majority of commenters fiercely opposed it. The firm pointed out that the rollback directly shifts evaluation, governance, and liability burdens to providers and health systems and away from the multibillion-dollar software vendors that design, sell, and profit from the tools. HHS officials attempted to cover their retreat by pointing to civil rights laws. In the final rule, ONC argued that because health care providers remain subject to Section 1557 of the Affordable Care Act and its implementing rule at 45 CFR Section 92.210—which prohibits federally funded health programs from using discriminatory clinical decision tools—mandatory vendor certification standards are redundant. Think about the brazen cruelty of that defense. The federal government tells electronic health record vendors they are completely exempt from proving their software is safe or unbiased. At the same time, it tells frontline hospitals and doctors that if the vendor’s black-box algorithm discriminates against a patient, the hospital and the doctor will be held strictly liable under federal civil rights law and state medical malpractice statutes. The developer takes the profit and hides the code. The hospital buys the software because it has no choice in a monopolized market. When the software malfunctions, the doctor takes the blame, the hospital pays the legal settlement, and the patient suffers the physical consequence. It is an airtight racket. Public Pushback and the Next Battleground. The only reason HTI-5 was not even more destructive is that the health technology lobby overplayed its hand. In the administration’s initial December 2025 proposed rule, political appointees attempted to eliminate thirty-four of the sixty federal certification criteria—including all thirteen core privacy and security standards. Regulators proposed repealing mandatory multifactor authentication and federally audited security logs, a reckless giveaway that would have left the nation’s critical health care infrastructure completely undefended against ransomware syndicates and foreign hackers. That initial proposal triggered a furious revolt from cybersecurity researchers, hospital systems, and clinical groups. Confronted with near-universal opposition during the public comment period, ONC was forced into an embarrassing partial retreat, preserving baseline privacy and security rules under Section 170.315(d) for future review. Similarly, federal regulators were forced to defer radical changes to information-blocking rules under the 21st Century Cures Act. The administration had sought to rewrite the legal definitions of data access and use to allow autonomous commercial AI agents to scrape patient records without restriction, while gutting the Trusted Exchange Framework and Common Agreement exceptions that protect patient privacy. Regulators punted those controversial provisions into an upcoming HTI-6 rulemaking cycle slated for late 2026 or early 2027. These tactical retreats prove that public outrage can halt the most egregious corporate giveaways. But on the central frontier of modern medicine—the rapid, uncontrolled deployment of black-box clinical algorithms—the tech lobby won everything it asked for. Starting December 28, 2026, when the repeal takes effect, the meager transparency standards that once held health software developers accountable will be officially erased from federal law. With Washington fully captured by health tech lobbyists, the fight over algorithmic safety will shift downstream. State legislatures and state insurance commissioners are already facing demands from patient advocates and civil rights organizations to pass state-level transparency mandates, filling the void left by federal abdication. Meanwhile, clinical unions and physician associations will have to confront software vendors directly at the bargaining table, demanding contract clauses that refuse to deploy automated diagnostic tools unless full, unredacted model cards are made available to the medical staff. The struggle over medical artificial intelligence was never about paperwork. It is about power: whether the digital tools governing human life and death will answer to doctors, patients, and democratic standards of proof, or whether they will operate as proprietary profit engines for a handful of corporate monopolies shielded by the state. In HTI-5, Washington made its allegiance unmistakably clear. The tech barons got their $1.55 billion check. The rest of us will have to live—or die—with the black box.